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Research and Field Applications of
Contraceptives in White-Tailed Deer, Feral
Horses, and Mountain Goats
Robert J. Warren, Richard A. Fayrer-Hosken, Lisa I. Muller,
L. Paige Willis, and Robin B. Goodloe

Abstract: This paper reviews our applications of longacting implantable steroids and immunocontraceptives in
selected wild ungulates. We implanted captive white-tailed
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Introduction

White-Tailed Deer

Recently, wildlife managers
have had to consider
.
controlling populations of wild and feral ungulates by
nonlethal means (Warren 1995). Public opposition,
legislative mandates, human safety concerns, or
budgetary limitations often make the application of
traditional methods of hunting, controlled shooting,
poisoning, or trapping-and-relocation programs
unacceptable management alternatives. Therefore,
interest and research in wildlife contraception has
increased dramatically in the past decade.

Need for Control

This paper will review our research and other
published applications of contraceptives in white-tailed
deer (Odocoileus virginianus), feral horses (Equus
caballus), and mountain goats (Oreamnos
americanus) with the assumption that these methods
must be practical, safe, and time and cost effective to
be useful in wildlife management. We believe that two
primary contraceptive tools have potential applicability
in these species: long-acting, implantable steroids
and immunocontraceptive vaccines. Most Of Our work
in this area has focused on development and evaluation of these wildlife contraceptives and evaluation of
delivery-method efficacy.

White-tailed deer have become so overabundant in
many areas of the United States that they now represent a significant problem for natural resource managers. Warren (1991) reviewed the historical causes of
this problem and presented an ecological justification
for control of overabundant deer populations in
national parks, In addition to ecological concerns,
overpopulated deer herds also represent a public
health and safety risk and cause significant economic
losses in the form of crop damage, damage to landscape plantings, and damage from deer-vehicle
collisions (Conover and Decker 1991, Curtis and
Richmond 1992).
While regulated public hunting can effectively

control deer populations (Behrend et al, 1970), it
cannot be used as a management technique in some
areas (e.g., national or State parks and urban or
suburban areas). Hence, there has been great public
interest in contraception as a technique for controlling
deer populations in these areas. But before they will
be accepted by wildlife managers for routine use in
deer population control programs, contraceptives must
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be safe, effective, easily administrable, and, ideally,
capable of lasting the reproductive lifespan of the doe
(Matschke 1980).

Contraceptive Steroids
Oral administration of the synthetic progesterone
melengestrol acetate (MA) (Roughton 1979) or the
synthetic estrogen diethylstilbestrol (DES) (Harder and
Peterle 1974) can inhibit ovulation in female deer, but
these contraceptives are not practical because they
require daily oral exposure. Microencapsulation of
DES can extend the effective treatment interval to
30 days, but these high doses are not readily eaten by
deer (Matchke 1977a).
Subcutaneous steroid implants can increase
treatment intervals to several months or years, but
these techniques require costly trapping and handling
of individual deer. Silicone tubing implants containing
MA and DES have successfully reduced reproductive
rates in deer for 1 to 2 years (Bell and Peterle 1975).
Matschke examined fertility control in deer with
SilasticB implants of DES and a synthetic progestin
(DRC-6246). Calculated release times for DES were
1-2 years v. 3 years for DRC-6246 (Matschke 1977b);
however, suppressed reproduction in the field lasted
only 2 years before depletion of DRC-6246 occurred
(Matschke 1980).
Implants containing MA have caused infertility in
nonpregnant captive deer for 2 years (Plotka and Seal
1989). When the implants were applied to pregnant
does during winter, however, pregnancy was not
terminated, and the implants had to be removed.
Plotka and Seal recommended that pregnant deer not
be treated with MA implants unless pregnancy is
terminated. It is unfortunate that these contraceptive
steroid implants cannot be used in winter during
pregnancy because at that time deer generally are
easiest to bait, capture, and treat.
Levonorgestrel (LNG) is an implantable progestin
that provides effective, long-term (>5-year) contraception in humans (Diaz et al. 1982). Contraception of
deer for >5 years from one treatment may justify the
time and cost associated with capturing and treating
individual deer and hence increase the potential for

providing a practical technique for contraceptive
management of deer populations.
Despite the potential for this deer contraceptive,
two studies with LNG implants in captive white-tailed
deer have shown this device to be ineffective. In the
first study, Plotka and Seal (1989) implanted five does
with a single homogenous silicone rod containing
200 mg LNG, and three of the five does became
pregnant. Plotka and Seal did not measure LNG
concentrations, so the lack of contraception may have
been related to the shape and matrix of the implant,
both of which can affect steroid hormone release
(Robertson et al. 1983).
White et al. (1994) also tested LNG implants in
deer but used the technique as it is applied in humans
(i.e., 216 mg of LNG sealed inside six small silicone
tubes). White's team compared six v nine LNG
implants (containing a total of 216 v. 324 mg of LNG)
in adult 1.: fawn does. Fawns were included to determine the effects of LNG implantation on puberty
attainment. Despite significant release of LNG from
both doses of implants, three of five implanted adults
and one of two fawns that survived 2 years after
implantation became pregnant.
Norgestomet (NGM) is a synthetic progestin that
has been applied successfully as a contraceptive in
white-tailed deer (Kesler, this volume) and black-tailed
deer (Odocoileus hemionus) (Jacobsen et al. 1995).
This hormone originally was marketed for synchronizing estrus in domestic livestock. Antech Laboratories,
Inc. (Champaign, IL), has complexed 42 mg of NGM
into silicone rods and loaded it into biobullets
(Kreeger, this volume) for remote delivery (Kesler, this
volume). In both species of deer, NGM was nearly
100-percent successful in preventing pregnancies but
it was effective for only 1 year (Jacobsen et al. 1995;
Kesler, this volume). Therefore, annual treatments
would be required to maintain control over deer
reproduction. This requirement would limit the applicability of this contraceptive technique primarily to
smaller populations and small areas where there is
substantial control over the deer herd.

Contraceptlves In White-Tailed Deer,
Feral Horses. and Mountain Goats

lmmunocontraceptives
The basic principle of immunocontraception is to
produce endogenous antibodies against a particular
protein or peptide involved in the reproductive process. Sufficiently high antibody titers disrupt the
function of the protein and cause contraception.
Infertility is maintained as long as antibody titer levels
remain high. However, fertility can resume after
exposure to the antigen has ceased and the antibody
titers decrease (Primakoff et al. 1988). For whitetailed deer, the proteins that have been evaluated as
immunocontraceptive antigens have been the oocyte
ZP and spermatozoa plasma membrane proteins.
lmmunocontraceptives have numerous advantages over contraceptive steroids that may make the
former more effective and efficient for use in deer.
lmmunocontraceptives can be delivered remotely,
which makes them more feasible for field application
than methods that require capture and immobilization
of individual deer. Also, a protein-based vaccine likely
would be deactivated if ingested orally by nontarget
organisms, in contrast to the persistent tissue residues
that often characterize the synthetic steroids. Digestion of the vaccine after oral ingestion also probably
would prevent unintentional transfer to carnivores or
humans.
Turner et al. (1992) successfully used porcine
zona pellucida (PZP) antigen in an immunocontraceptive
for white-tailed deer. Turner's team vaccinated whitetailed does with 5,000 heat-solubilized porcine zonae
pellucidae (64.3 p g protein) emulsified in 0.5 cm3
Freund's Complete Adjuvant and delivered remotely in
a 1-cm3self-injecting dart. Booster injections of PZP
emulsified in Freund's Incomplete Adjuvant were given
3-6 weeks after the initial injection. Six months after
onset of the injection scheme, the does were bred to a
healthy buck of known fertility. None of the ZP-treated
does but six of seven (86 percent) of the control does
produced fawns.
The requirement of multiple booster injections
limits the practicality of using this contraceptive
vaccine in free-ranging deer populations. However,
recent advances in research with PZP include microencapsulation of the booster vaccinations, which

allows release of the booster over a period of weeks
or months so that only 1 vaccinationlyear is required
(J. F. Kirkpatrick, pers. comm.; Stevens et al. 1992).
Several different sperm proteins also have been
considered for use in immunocontraceptive vaccines
(Naz and Menge 1990). Antisperm vaccination may
cause infertility in the male or female. In the male,
antisperm antibodies may cause an autoimmune
response to the sperm, thus resulting in infertility
(Mathur et al. 1988). Treating bucks in a free-ranging
deer population with an antisperm vaccine would have
limited effect on the reproductive rate of the herd
because deer are polygynous breeders. However,
applying an antisperm vaccine may be more practical
if males and females do not have to be distinguished
prior to treatment.
In the female, antisperm antibodies may cause
agglutination of sperm (reviewed in Shulman 1986),
reduced penetration of sperm through the cervical
mucus (Clarke 1988), or altered sperm binding to the
zona pellucida (Naz et al. 1992). Antisperm vaccines
also may be "self-boosted" (i.e., additional exposure
and boosting of the immunity against sperm may
occur with each insemination). Some women with
spontaneous sperm-antibody titers have reduced titers
following the use ot condoms, wh~chprobably function
to prevent boosting from sperm in the vagina (reviewed
in Shulman 1986). Thus, if antisperm vaccines are
self-boosting, they may be more practical for field
application than multiple booster vaccinations of
antiporcine ZP vaccines.
Very little research exists on the use of antisperm
vaccines in deer. To date, our research laboratory has
presented the only data available on antisperm
vaccines for deer (White et al. 1993). We developed
antisperm vaccines using anterior acrosomal sperm
plasma membranes from deer, bull, and boar sperm.
These vaccines were injected into adult does, from
which blood samples were collected for antibody titer
analysis. High antisperm antibody titers occurred in
does injected with antisperm vaccines made from all
species tested. However, antibody recognition of deer
sperm was greatest in those does injected with either
deer or boar sperm. Despite high antibody titers that
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persisted for at least 11 months after immunization,
the does treated in this preliminary trial became
pregnant.

Feral Horses
Need for Control
Feral horses occupy extensive areas of public land in
the United States. Historically, these herds were
controlled by local citizens who captured wild horses
for use as beasts of burden, in pet food, and as rodeo
stock. In 1971, the Wild Free-Roaming Horse and
Burro Act (Public Laws 86-234 and 92-1 95) specifically eliminated these uses and required Federal
agencies to control feral horses through capture and
adoption (Wagner 1983). The adoption program has
been very costly and unsuccessful. The cost of
capture and adoption of each feral horse ranges from
$300 (Turner and Kirkpatrick 1986) to more than
$1,800 (Godfrey and Lawson 1986). In 1985, the
Federal Government spent more than $5 million to
remove and maintain up to 18,000 feral horses and
burros through the "Adopt-a-Horse" program (Boyles
1986). Many of the horses captured were older
stallions and were not in demand by potential adopters
(Slade and Godfrey 1982). Clearly, alternative techniques for managing feral horse populations are
needed.

on their simulation analyses, Garrott and coworkers
concluded that contraceptives could reduce substantially the number of horses that would have to be
removed from Federal lands each year. Thus, fertility
control may represent an effective alternative for feral
horse population control that may be more economically feasible than maintenance and placement of
excess horses in the Adopt-a-Horse programs.

Contraceptive Steroids
The harem breeding structure of feral horses, in which
a dominant stallion breeds most of the mares in a
particular harem, permits the use of male-based
wildlife contraception management programs for this
species. Turner and Kirkpatrick (1982) administered a
microencapsulated form of testosterone propionate
(MTP, given intramuscularly) to feral stallions. Foal
counts were reduced to 0.07 foalimare for MTPtreated bands compared to 0.37 for mares in control
bands. The investigators also observed no differences in stallion behavior parameters, such as scent
marking in response to mare elimination marking,
mounting, or copulation. The primary advantage to
this type of treatment was that the fertility of an entire
herd could be controlled through the treatment of a
single stallion. Disadvantages included the fact that
immobilization of the stallion and multiple injections
were required, resulting in high cost and hard work.

Public sentiment and interest in feral horses is
extremely high. This fact has led to the tremendous
amount of political support this species has received.
Visitors to national wildlife refuges and national parks
that contain feral horses are very interested in observing these animals. Yet the agencies charged with
managing these herds are faced with a dilemma: how
to control the feral horse populations so as to minimize the effects of overgrazing on native vegetative
communities and still meet public interest needs and1
or comply with the Wild Free-Roaming Horse and
Burro Act in a manner that is logistically and fiscally
feasible.

In a subsequent study, Kirkpatrick and Turner
(1987 unpubl.; also cited in Turner and Kirkpatrick
1991) used MTP to treat feral stallions in a different
population, each with a harem of proven fertility. In
this study, the stallions were treated remotely instead
of being immobilized. During the 5 years prior to
treatment, harem fertility rate ranged from 42 to 50
percent; the year after MTP treatment, the fertility rate
averaged 28.9 percent, compared to 45.4 percent for
control harems during the same year. This method of
contraception would require annual treatments and
probably would be less effective in bands having
sexually mature subordinate stallions or a high degree
of movement by mares between harems.

Garrott (1991) and Garrott et al. (1992) evaluated the potential and economic feasibility of fertility
control for managing feral horse populations. Based

Feral mares also have been treated with chemical contraceptives. Plotka et al. (1988) used silicone
implants with estradiol and/or progesterone to inhibit

Contraceptives in White-Tailed Deer,
Feral Horses, and Mountain Goats

ovulation. Plotka's team observed greater levels of
serum progesterone and estradiol for at least 21
weeks in treated mares but no reduction in ovulation
or conception. In a subsequent study, Plotka et al.
(1992) used silicone implants containing
ethinylestradiol, estradiol 17-beta, or progesterone.
The higher dosages of ethinylestradiol resulted in
contraceptive rates of at least 88 percent for 3 years,
with an estimated efficacy period up to 5 years.
Contraception occurred regardless of route of implant
delivery (subcutaneous, intramuscular, or intraperitoneal).
In another study, microencapsulated
norethisterone (MNET, a synthetic progestin) was
administered by remote delivery to six feral mares of
proven fertility (Kirkpatrick and Turner 1987 unpubl.,
Turner and Kirkpatrick 1991). No contraceptive effect
from this treatment was detected, which supported the
results of Plotka et al. (1988) for progesterone.
Applications of microencapsulated steroids have
a number of practical limitations. The microencapsulated suspension tends to settle out and clump if not
delivered within 10 minutes of mixing (Turner and
Kirkpatrick 1991). In addition, remote delivery of the
suspension via barbless or microbarbed darts, which
ultimately fall out of the animal, represents a potential
for environmental contamination from lost or unrecovered darts. The method also necessitates careful
calculation of velocity and trajectory in order to prevent rebound of the dart (Turner and Kirkpatrick 1991).

lmmunocontraceptives
For feral horses, the proteins that have been evaluated as immunocontraceptive antigens have been
hormones, the oocyte zona pellucida, and spermatozoa plasma membrane proteins. The only hormone
used as an antigen for equine immunocontraception
thus far has been luteinizing hormone-releasing
hormone (LHRH, also referred to as gonadotropinreleasing hormone or GnRH). This hormone is a
decapeptide released from the hypothalamus. The
immunogenicity of peptides generally is low; therefore,
LHRH must be conjugated to a larger protein to
increase the response by the immune system.

Safir et al. (1987) used LHRH conjugated to
human serum albumin (HSA) and combined with
Freund's Complete Adjuvant as an immunocontraceptive vaccine to inhibit ovulation in captive mares.
After multiple booster injections, three of five mares
immunized against LHRH failed to ovulate for at least
5 months (duration of the study), whereas five of five
untreated control mares ovulated. Inhibition of
folliculogenesis and ovulation was related directly to
LHRH antibody titers.
Field application of an LHRH immunocontraceptive vaccine has been evaluated in feral horses.
Goodloe (1991) used a vaccine composed of LHRH
(15 mg immunogenic activity) conjugated to keyhole
limpet hematocyanin (KLH) and mixed with one of two
adjuvants, either alum (AP) or Ribi ImmunoChem's
triple adjuvant (TA; 100 mg each monophosphoryl lipid
A, trehalose dimycolate, and Bacillus Calmette-Guerin
cell-wall skeleton). Initially, captive domestic mares
were given the vaccine as a means of monitoring
antibody titer levels. Vaccines were prepared in a
microencapsulated form for the first year of study in
captive mares; biobullet delivery was used for the
second year. The microencapsulated vaccine was
designed to release one dose immediately upon
injection, one dose in 2-3 months, and a final dose in
6-9 months. The microencapsulated vaccines could
not be delivered via biobullet because of its limited
payload capacity (300 mg).
During the first year of the study using microencapsulation, the vaccine with the TA adjuvant produced higher antibody titers than did the vaccine with
the AP adjuvant (Goodloe 1991). Three of the four
mares treated with the TA form of the vaccine ovulated
an average of 111 days after initial treatment, compared to a mean of 44 days for control mares. Thus,
this treatment delayed but did not significantly inhibit
ovulation. Microencapsulated vaccine also resulted in
swelling or an abscess at the injection site of each
mare.
During the second year of study, the same mares
were boosted remotely with a single biobullet. Although
it did not stimulate antibody production sufficient to
inhibit ovulation, this mode of vacination did not result
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in abscess formation. Overall, there were no significant differences between treatment and control mares
in terms of date of first ovulation, number of ovulations, or percentage of mares that became pregnant.

volumes of Freund's Complete or Incomplete Adjuvant. An initial and two booster vaccinations were
delivered remotely using self-injecting plastic syringe
darts tipped with barbless needles.

Goodloe (1991) applied the same vaccine via
biobullet followed by one booster injection 2-3 months
later and a second booster injection an additional
8 months later to 21 feral mares on Cumberland
Island, GA. The field study further substantiated the
results from the captive mares: foal production did not
differ between treated and untreated mares.

Of the 26 porcine ZP-treated mares, 3 developed
abscesses at the injection site after the third vaccination (Kirkpatrick et al. 1990). At the time of initial
injection, 14 of the 26 mares (57.6 percent) were pregnant, and all these gave birth to live foals 1-3 months
after the final injection. Similarly, two of the six control
mares produced live foals that same year. In the year
after vaccination, the foaling rate for mares treated
with porcine ZP was significantly lower the year after
treatment (3.8 percent) compared to the 2 years prior
to treatment (53.8 percent). In addition, foaling rates
were significantly lower for the 26 mares treated with
porcine ZP in the year after treatment (3.8 percent)
when compared to foaling rates for the six control
mares (50 percent) or the 11 untreated mares
(45.4 percent).

The differences in success between the studies
by Goodloe (1991) and Safir et al. (1987) could be due
to either the type of adjuvant or conjugate used, or to
the number of booster vaccinations given. However,
both studies indicate that LHRH-based immunocontraceptive vaccines may be expected to produce
infertility for at most a single breeding season, which
obviously limits the practicality of this method of
contraception for routine use in feral horse population
management programs.
The oocyte ZP also has been used as an immunogen for contraception in horses. Liu et al. (1989) used
a series of four vaccinations (given at 2- to 4-week
intervals) with heat- solubilized porcine ZP (64.3 kg)
and either aluminum hydroxide gel or Freund's Complete Adjuvant. Ten feral mares were vaccinated and
released into their natural territory, known to contain
fertile stallions. Eight months later, the mares were
recaptured, and their pregnancy status was determined by rectal palpation. Four domestic mares also
were treated and monitored in captivity. Contraception
occurred in 12 of the 14 (86 percent) fertile mares
studied.
Subsequently, Kirkpatrick et al. (1990) evaluated
the applicability of this porcine ZP vaccine to feral
horse populations on Assateague Island, MD. The
investigators selected sexually mature mares with
known breeding histories; 26 mares were treated with
the porcine ZP vaccine, six control mares were
injected with phosphate buffer and adjuvant, and
11 mares served as untreated controls. The vaccine
contained 5,000 heat-solubilized porcine zonae
pellucidae (64.3 pg protein) emulsified with equal

Kirkpatrick et al. (1990) had difficultly in relocating all mares they initially injected. Of those that were
relocated, some had become very wary and could not
be given booster vaccinations. Subsequent work by
this research team has focused on developing a oneshot injection in which a booster vaccination is microencapsulated (J. F. Kirkpatrick, pers. comm.).
Kirkpatrick et al. (1991) continued this study and
gave booster vaccinations to 14 of the original 26
mares treated with porcine ZP approximately 1 year
following the initial treatment. Foaling data collected
in the subsequent year indicated that foals were
produced by 1 of 14 (7 percent) boosted mares, 3 of 6
(50 percent) control mares, and 7 of 16 (44 percent)
untreated mares. During a third year for the same
study, Kirkpatrick et al. (1992) treated 10 of the mares
boosted during the second year with another identical
vaccination. None of the 10 mares boosted for a third
consecutive year became pregnant, as opposed to 11
of 20 (55 percent) control mares. The researchers
also used intensive visual observations and urinary
analysis to monitor behavioral estrus and ovarian
function for seven of the treated and four of the control
mares. Based on these analyses, only two of the
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seven treated mares demonstrated ovulatory cycles.
The lack of cyclicity was thought to be due to altered
ovarian function as has been shown to occur in other
species given a similar vaccine (Skinner et al. 1984,
Dunbar et al. 1989).
Thus, the porcine ZP vaccine has been shown to
be very effective as an immunocontraceptive in feral
horses. However, the formulation of porcine ZP
vaccine used by Kirkpatrick et al. (1990, 1991, 1992)
has certain characteristics that may limit its practical
applicability in the field. Use of Freund's Complete
Adjuvant in the vaccine is a distinct disadvantage.
Most approved veterinary vaccination protocols do not
permit the use of Freund's Complete Adjuvant in any
applications other than small-scale, experimental
trials. Therefore, a porcine ZP vaccine containing this
adjuvant probably will not be approved for routine use
in feral horse population-control programs. In addition, because Freund's Adjuvant cannot be lyophilized,
a vaccine incorporating it must be administered as a
liquid in a syringe dart as opposed to the biobullet.
Because of the above-mentioned concerns over
the use of Freund's Adjuvant, Willis et al. (1994b)
evaluated the use of an alternative formulation of the
porcine ZP vaccine for horse contraception. The Willis
team's formulation contained 200 pg of porcine ZP
antigen and 500 pg of synthetic trehalose
dicotynomycolate glycolipid (Ribi ImunoChem Research,
Inc., Hamilton, MT) as an adjuvant. This porcine ZP
vaccine formulation was lyophilized and packed into
biobullets (Kreeger, this volume) for remote delivery to
captive horses. Goodloe (1991) had previously
documented the efficacy of this method for remote
delivery of immunocontraceptives to free-ranging feral
horses. Willis et al. (199413) treated four mares with
an initial and one booster vaccination separated by
1 month. Four control mares were injected with
biobullets containing only the adjuvant. All mares
were bled for antibody titer analysis and bred to a
sexually mature stallion at each estrous period
through two complete breeding seasons. The control
mares had no titer levels and conceived during their
first estrous period, in contrast to three of the four
mares treated with porcine ZP, which had high
antiporcine ZP titers and did not conceive. The fourth

treated mare had lower titer levels and was fertile, but
she too became infertile after administration of a
subsequent booster vaccination.
Willis et al. (1994b) monitored antibody titer
levels and infertility during the breeding season the
year after initial treatment and, despite not having
received a booster vaccination in the second year of
this study, all of the treated mares continued to have
high titer levels and were infertile. The greater potential duration of contraceptive effect apparent for this
porcine ZP vaccine formulation may greatly improve
its field applicability compared to other formulations
that require annual booster vaccinations.
Sperm proteins also have potential for being
used as antigens in immunocontraceptive vaccines,
although relatively little research has been done in this
area with horses. The most extensively characterized
sperm immunocontraceptive thus far was developed
by Naz et al. (1984). Naz and coworkers developed a
monoclonal antibody (MA-24) in the mouse that
specifically recognized a glycoprotein found only on
the postacrosome, midpiece, and tail of sperm. This
glycoprotein was termed fertilization antigen 1 (FA-1).
FA-1 was determined to be nonspecies specific
because the MA-24 antibody cross-reacted with
sperm from mice, rabbits, rhesus monkeys, and bulls
(Naz and Menge 1990). The MA-24 antibody apparently causes contraception by blocking sperm-egg
binding. Treatment of sperm with either the MA-24
antibody or antiserum against FA-1 prior to insemination significantly reduced in vitro fertilization rates as
compared to untreated sperm (Naz 1987). In addition,
female rabbits immunized with purified FA-1 had
significantly lower in vivo fertilization rates (14.7
percent) as compared to control rabbits (91.7 percent)
(Naz et al. 1986).
The only research published to date in the area of
sperm plasma-membrane protein immunocontraception
in horses was done in our research laboratory (Willis
1993, Willis et al. 1994a). We developed antisperm
vaccines using plasma membrane proteins from
porcine and equine sperm. These vaccines were
adjuvented with synthetic trehalose dicorynomycolate
glycolipid, lyophilized, and administered via biobullet
to two captive mares. Four mares served as controls
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and received biobullets containing only the adjuvant.
All mares were bred to a fertile stallion, and blood
samples were collected for antibody titer analysis.
High antisperm antibody titers were detected in the
treated mares, but no significant differences occurred
in conception: one of two treated mares became
pregnant compared to three of four controls.

Mountain Goats
Need for Control
The mountain goat is a native species in some mountainous habitats in North America. However, there is
debate over its status as a native species on the
Olympic Peninsula of western Washington. National
Park Service (NPS) scientists in Olympic National
Park maintain that the mountain goats were artificially
introduced into this park by humans in the 1920's
(Moorhead and Stevens 1982). Conversely, Lyman
(1988) argued that this species may have become
locally extinct on the Olympic Peninsula prior to the
first biological surveys in the late 19th and early 20th
centuries. If Lyman is correct, mountain goats may
not be exotics in the park.
The status (i.e., native or exotic) of mountain
goats in this park is very important because NPS
management policies encourage the elimination of
exotic species that may threaten the survival of native
species. Ecological research conducted in the park
has shown that fragile alpine plant communities are
being threatened by grazing pressure from mountain
goats (Olympic National Park 1981 and 1987). Because
of this concern, NPS began a capture-and-removal
program in 1981 to reduce or eliminate mountain
goats from the park (Houston and Stevens 1988,
Carlquist 1990, Houston et al. 1991). This removal
program has been very costly (as much as $9001,000 per goat removed) (Houston et al. 1991).
Therefore, NPS has experimented with fertility control
as a more cost-effective means of controlling mountain goats in the park. Lethal removal of mountain
goats, while acceptable and cost effective for control

of feral goats in some countries (Parkes 1990), is very
controversial in the United States.

Contraceptive Steroids
In deciding which contraceptive techniques to evaluate, NPS scientists considered a number of criteria:
ease of application in the field, safety to goats and
humans, potential for treating a large proportion of the
population, duration of efficacy, and cost. In an
experimental evaluation of contraceptive and sterilization methods to control goats in Olympic National
Park, Hoffman and Wright (1990) captured and placed
silicone implants containing MA in the neck region of
11 female mountain goats. The investigators also
captured five male goats in a different portion of the
park and injected their epididymis with a sclerosing
agent containing lactic acid (ChemcastTM,BioCeutic
Laboratories, Inc., St. Joseph, MO). The females
were monitored in the field for a period of 5 years,
during which the rate of kid production averaged
10 percent as compared to 68 percent for a similar
group of untreated females in the park during the
same time period. Comparative examination of the
treated males 2 years after treatment confirmed
blockage of their epididymides and sterilization.
However, visual monitoring of the area occupied by
the males for 2 years after treatment revealed no
change in population size or the rate of kid production
by females. Male-based contraceptive techniques
obviously have limited potential for success in a wild,
polygynous species. Hoffman and Wright (1990)
concluded that the techniques they tested might have
potential for controlling the numbers of mountain goats
in the park. However, the requirement that goats had
to be captured for treatment made these techniques
very expensive and limited their widespread operational application over a larger portion of the park. In
addition, captures by helicopter, which were mandatory for capturing mountain goats in the park, were
discouraged in 1990 by the U.S. Department of the
Interior's Office of Aircraft Safety after a risk assessment revealed that the goat capture procedures
represented a significant human safety hazard (Tuler
et al. 1992).

Contraceptives in White-Tailed Deer,
Feral Horses, and Mountain Goats

Immunocontraceptives
No published research is available on immunocontraceptives in mountain goats. lmmunocontraception may
have potential for application in Olympic National
Park. However, logistical and fiscal limitations associated with fieldwork in this park will necessitate longacting (preferably permanent) immunocontraceptives
that can be delivered remotely via a biobullet or
syringe dart shot from a helicopter. Field application
of remotely delivered immunocontraceptives from a
helicopter in the rugged, mountainous terrain of
Olympic National Park likely represents the most
difficult situation for contraceptive management of a
wildlife population.

Conclusions and Practical
Applicability
The above literature review demonstrates that several
available contraceptive techniques are effective in
individually treated deer, horses, and mountain goats.
Additional literature on the application of contraceptives in other species has been reviewed by Bomford
(1990) and Kirkpatrick and Turner (1991). Despite the
success of some contraceptives in individually treated
animals or in captive situations, management of
wildlife populations with contraceptives may be
infeasible if they are not practically applicable in the
field. More research is needed to document that
contraceptives can be effective when applied as a
management technique at the population level.
Garrott (1995) published results of a study that used
computer simulations to consider the prospects of
controlling wildlife populations with contraceptive
techniques. However, nobody will know the true
potential for contraceptive management until these
techniques are tested under real-world conditions
where feasibility of field applicability, interactions
among ecological factors and processes, the potential
population-level efficacy of treatments, and considerations of time and cost efficiency become paramount
to the success or failure of any program for wildlife
contraception.

A number of important practical questions exist
relative to the potential applicability of contraception in
wildlife management. Aside from the questions about
the efficacy of the particular contraceptive agent, its
duration of effect, and its safety to treated animals are
important questions relative to the potential effects of
the agent on the ecological food chain. In this regard,
contraceptive vaccines likely will be safer than contraceptive steroids. Nonetheless, research is needed to
determine the extent to which contraceptive vaccines
may be effective after ingestion by nontarget organisms, including humans. lmmunocontraceptives will
not be approved by Federal and State regulatory
agencies for routine field implementation in wildlife
management programs until these potential secondary
effects are documented as being environmentally
insignificant.
Interactions among ecological processes will
likely exert a great effect on the success of wildlife
contraceptive-management programs. Reduced
reproduction by females treated with contraceptives
may provide greater chances for survival of offspring
born to other untreated females in the population. In
other words, there may be a compensatory increase in
juvenile survival. Additionally, reductions in a particular population because of reduced reproduction could
be offset by immigration of individuals from areas
surrounding the treatment area.
Time and cost efficiency are extremely important
issues when considering wildlife contraceptivemanagement programs. The contraceptive agents
themselves may be economical, but the personnel and
operating expenses associated with delivering contraceptives to significant proportions of individuals in a
wildlife population likely will be cost prohibitive. State
wildlife agencies obtain much of their funding from
sales of hunting and fishing licenses and Federal aid
funds for wildlife restoration (e.g., the PittmanRobertson tax). Therefore, it may be inappropriate for
these agencies to use these revenues for contraceptive management programs. Alternate State, Federal,
municipal, or private funds probably will be required to
support contraceptive management programs.

Contraception in Wildlife Management

The nature of the wildlife management profession has changed greatly in the United States during
the past few decades. Societal changes have altered
the opinions and expectations of the public we serve.
Wildlife biologists and managers are entrusted by the
public with the responsibility of managing our wildlife
resources. Nonlethal techniques for wildlife population management are increasingly demanded by the
public in some situations. The potential for contraception to become a successful wildlife population management technique in certain publicly sensitive
situations is great. Wildlife biologists have a professional obligation to consider all possible techniques for
use in wildlife population management.
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